Clinical trial
Efficacy of Seroquel SR in Combination With an Antidepressant in Treatment of…
NCT00351169 · AstraZeneca, Industry · Completed
Key facts
| NCT number | NCT00351169 |
|---|---|
| Title | Efficacy of Seroquel SR in Combination With an Antidepressant in Treatment of Major Depressive Disorder |
| Official title | A Multi-Centre, Double-Blind, Randomised, Parallel Group, Placebo- Controlled and Active Controlled Phase III Study of the Efficacy and Safety of Quetiapine Fumarate Sustained Release (Seroquel SRTM) as Mono- Therapy in the Treatment of Adult Patients With Major Depressive Disorder |
| Acronym | AMBER |
| Lead sponsor | AstraZeneca, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Major Depressive Disorder |
| Intervention type | Drug |
| Interventions | Quetiapine SR, Escitalopram |
| Enrollment | 450 |
| Start date | May 1, 2006 |
| Completion | Jun 1, 2007 |
| First posted | Jul 12, 2006 |
| Last update posted | Dec 22, 2008 |
| Countries | Canada, China, Finland, Malaysia, Mexico, Philippines, South Africa, South Korea, Spain |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: